Navigation Links
MultiVu Video Feed: SCIELE PHARMA ANNOUNCES AVAILABILITY OF ULESFIA(TM), FIRST AND ONLY FDA-APPROVED NON-NEUROTOXIC HEAD LICE TREATMENT
Date:8/5/2009

Sciele Pharma, Inc., a Shionogi Company, today announced the availability of Ulesfia (Benzyl Alcohol Lotion 5%), the first and only prescription medication that kills head lice by asphyxiation without potential neurotoxic side effects. Approved by the U.S. Food & Drug Administration (FDA), Ulesfia is available now by prescription nationwide in time for peak head lice season as children will shortly be headed back to school.

Each year, approximately 6 to 12 million children between the ages of 3 and 12 years are infested with head lice, parasites that survive by injecting small amounts of saliva and removing small amounts of blood from the scalp every few hours. To survive, lice breathe through sophisticated breathing holes that close upon contact with most liquids, allowing the lice to go into suspended animation and survive for hours without respiration. Ulesfia's unique mechanism of action is facilitated through the use of benzyl alcohol which prevents lice from closing their breathing holes, thereby asphyxiating them and causing death. Ulesfia is an effective head lice treatment that does not contain harsh chemicals and addresses the increasing resistance of lice to therapies that contain neurotoxic chemicals.

Full prescribing information for Ulesfia (Benzyl Alcohol Lotion 5%) is available at www.sciele.com.

    SATELLITE FEEDS:
    Wednesday, August 5th, 2009        Thursday, August 6th, 2009
    1:00 PM - 1:15 PM ET               1:00 PM - 1:15 PM ET
    AMC 3                              AMC 3
    C-Band                             C-Band
    Transponder 3                      Transponder 3
    Downlink Freq. 3760 Horizontal     Downlink Freq. 3760 Horizontal

NEWS: Unique Product Asphyxiates Head Lice, Can Help With Outbreaks as Children Head Back to School

FORMAT: B-roll and Soundbites

ADDITIONAL RESOURCES: Video, contact information and more available at: http://www.prnewswire.com/broadcast/37282/consumer.html


    SOUNDBITES:
    * Ronald Hansen, M.D., Chief of Pediatric Dermatology, Phoenix Children's
      Hospital
    * Judith O'Haver, RN, MS, CPNP, Nurse Practitioner, Phoenix Children's
      Hospital

    B-ROLL INCLUDES:
    * Children at camp and school - Head lice images - Young girl patient
      with doctor -- Nurse combing out girl's hair - Ulesfia product shot

VIDEO PROVIDED BY: Sciele Pharma, Inc., a Shionogi Company

Contact: FOR MORE INFORMATION, PLEASE CALL: MultiVu Media Relations, 1-800-653-5313 EXT. 3


'/>"/>
SOURCE Sciele Pharma, Inc., a Shionogi Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MultiVu Video Feed: PUBLIC HEALTH EXPERTS CONVENE TO DISCUSS THE TREATMENT AND PREVENTION OF RABIES
2. MultiVu Video Feed: FDA Approves DORIBAX(TM) (doripenem for injection) for the Treatment of Complicated Intra-abdominal and Complicated Urinary Tract Infections
3. MultiVu Video Feed: Parents of Kids With Infectious Diseases Sounds Alarm About the Dangers of Pertussis With "Silence the Sounds of Pertussis" Campaign
4. MultiVu Video Feed: STARLIGHT STARBRIGHT UNVEILS GET FIT, GET RIGHT A PROGRAM TO PREVENT TYPE 2 DIABETES AND WEIGHT-RELATED CONDITIONS IN TEENS
5. MultiVu Video Feed: NEW SURVEY FINDS THAT HALF OF CAREGIVERS SPEND 10 PERCENT OF THEIR INCOME CARING FOR AN OLDER LOVED ONE
6. Photo: MultiVu Promotes George DeTorres to Divisional Vice President for the MultiVu Healthcare Team
7. MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA APPROVAL FOR GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES MELITUS
8. MultiVu Video Feed: LIFE AND STYLE EXPERT SANDRA LEE OFFERS RECIPES AND SHORTCUTS IN THE KITCHEN TO PEOPLE WITH RHEUMATOID ARTHRITIS
9. MultiVu Video Feed: New National Colorectal Cancer Screening Guidelines Issued by the American Cancer Society
10. MultiVu Video Feed: Stinky Sneakers Worth Big Money!
11. MultiVu Video Feed: Podiatrists Keep America Walking
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... March 22, 2017 , ... ... California and Nevada and LABS, Inc., announced the future opening of a CLIA ... screening and serology testing used to determine the suitability of potential organ ...
(Date:3/22/2017)... ... ... Wash Tower Ltd. has released a series of six viral poo-related teaser ... standalone constant pressure bidet. , The videos in the series titled "The Adventures of ... well as on its social media pages. , Each video stars Arthur the Butler ...
(Date:3/22/2017)... ... 2017 , ... The Rett Syndrome Research Trust (RSRT) announced ... afflicts 350,000 individuals worldwide. Rett Syndrome is caused by alterations in a ... Following a normal infancy, Rett Syndrome takes effect in toddlerhood depriving children ...
(Date:3/22/2017)... ... 2017 , ... Drs. Jennifer Houck, Lauren Smith, Heather Johnson and the India ... need of skilled pediatric dentistry in Rock Hill, SC, without a referral. ... treatments, including cavities, sealants and fluoride applications, in a comfortable and fun environment. , ...
(Date:3/22/2017)... , ... March 22, 2017 , ... ... entered into a research collaboration to translate advances in basic neuroscience at the ... Blythedale and beyond. The collaboration seeks to improve movement, vision, and cognition impaired by ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... solutions, today reported financial and operational results for ... 31, 2016. 2016 Highlights ... compared to the full year 2015  ... year  Direct-to-consumer model launched in ...
(Date:3/22/2017)... today announced the appointment of Martyn Coombs as Chief ... ImaginAb, said "At ImaginAb we have exciting science and technology. Martyn ... business, particularly in commercializing and making step changes in the value ... our potential." ... Coombs is a recognized industry leader in nuclear medicine and imaging. ...
(Date:3/22/2017)... -- Ablation is the minimally invasive therapeutic tissue excision ... from cancerous or diseased tissue removal, to the ... fibrillation and others. The growing adoption of minimally ... and improvise existing ablation technologies for better patient ... is expected to grow at high single digit ...
Breaking Medicine Technology: